Nov 14 (Reuters) - Aptose Biosciences Inc
* Aptose reports results for the third quarter ended September 30, 2017
* Q3 loss per share C$0.14
* Aptose Biosciences Inc - total cash and cash equivalents and investments as of September 30, 2017 were $13.6 million Source text for Eikon: Further company coverage:
Our Standards: The Thomson Reuters Trust Principles.